Health
2.1
Celon Pharma files for marketing authorization of semaglutide injection (Ozempic equivalent)
Published 1 d ago1 sourceEvidence: Reported
ParkietLow-rated sourcePL
HealthReportedLow
1.9
GLP-1 drugs linked to hair loss and nail issues, scientists flag
Observational reports and preliminary studies suggest GLP-1 receptor agonists (Ozempic, Mounjaro, etc.) may be associated with alopecia and nail abnormalities. The mechanism is unclear, possibly related to rapid weight loss or nutritional deficiencies. Regulatory scrutiny may increase, but no causal link is confirmed.
Score Breakdown
Mosaic Score1.9
Model confidence0.3
Significance0.1
Source credibility0.3
Intelligence Tags
Related signals
8 foundMarkets
6.0
US Stocks Slide, Tech Hit Hardest; Pharma Rebounds
Published 2 d ago3 sourcesEvidence: Reported
SeverityModerateAssessedDeveloping storyDagens IndustriLow-rated sourceUS
Justice
5.7
SEB settlement reveals sanctions-check failures in Baltics
Published 1 d ago2 sourcesEvidence: Reported
SeverityModerateDagens IndustriLow-rated sourceSE · EE · LV
Health
5.3
GLP-1 drugs may mask anorexia symptoms, complicating diagnosis
Published 1 d ago2 sourcesEvidence: Reported
SeverityModerateAssessedDeveloping storyNew York TimesLow-rated sourceUS
Tech
5.2
Tesla unveils flying Roadster, targets 2028 release amid regulatory uncertainty
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateAssessedDeveloping storyAnadolu Agency ENUS
Markets
5.1
RBI clarifies Foreign Exchange Risk Reserve rules via FAQs
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateReserve Bank of India — Press ReleasesLow-rated sourceIN
Trade
5.1
JetSMART Chile gains ninth freedom rights, expands Brazil routes via Buenos Aires
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateLa Nación (Argentina)Low-rated sourceCL · AR · BR
Trade
5.1
US DOT lifts restrictions on Mexican airlines at AICM and AIFA
Published 16 h ago1 sourceEvidence: Reported
SeverityModerateEl FinancieroLow-rated sourceUS · MX